In a competitive environment, when there is an urgent need, making bold changes to your usual processes to save time can be critical to success.
Discover how our high-throughput antibody generation process was adapted to address the need for rapid delivery of customized reagents early in the COVID-19 pandemic. The combination of antibody phage display and our new modular antibody assembly platform based on SpyTag technology, reduced the time from antigen receipt to shipment of IgG-like antibodies to just four weeks.
You will learn:
Presented by: Dr Christian Frisch, R&D Manager, Bio-Rad Laboratories
Christian Frisch is R&D manager at Bio-Rad and has led the antibody generation group since 2003. He studied molecular biology in Göttingen (Germany) and did his Ph.D. with Prof. Alan Fersht at the University of Cambridge (UK) working on the energetics of protein-protein interactions and protein folding. In 1997 he joined MorphoSys AG, working on the development of display technologies and the generation of antibody phage display libraries. His group at Bio-Rad has generated more than 25,000 antibodies for custom projects over the last 13 years.
It’s easy to work with us:
Get more details about SpyTag technology, how it works with our antibody generation service, and see data for different experimental applications.